Purchase Order 75N93018P01139
Award Date 8/24/18
Potential Completion Date 11/29/22
Potential Value $101K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Menlo Park, CA 94025, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Pacific Biosciences of California, Inc. was awarded a $119,127 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases. This multiple delivery order contract, set aside for total small businesses, will provide PacBio kits and reagents to support genomic research initiatives through September 2021. The original solicitation requested brand name only PacBio reagents to fulfill sequencing...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $480,000.00 firm-fixed price contract to Pacific Biosciences of California, Inc. to provide a Sequel II DNA/RNA sequencing system and associated services. The contract is for the purchase and delivery of the sequencing system and on-site training, with a trade-in of a previous Sequel I system. This contract is not set aside for any small business program....
- This is a firm-fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Pacific Biosciences of California, Inc. for $35,000.00. The contract is for the provision of Pacific Biosciences' proprietary Sequel and Sequel II DNA/RNA sequencing platforms, associated consumables, and related support services. The contract was awarded on a sole-source basis, as Pacific Biosciences was determined to be the only responsible source capable of meeting NIAID's...
- This is a firm fixed-price purchase order awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) to Pacific Biosciences of California, Inc., a small business manufacturer of scientific equipment and reagents. The $227,225 contract provides NIAID's Vaccine Research Center with specialized single-molecule real-time (SMRT) sequencing kits and consumables, including SMRT cells, barcoded adapters, and binding reagents for their Sequel II DNA...
- This firm-fixed-price purchase order for $32,500.00 was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Pacific Biosciences of California, Inc. to provide their Sequel and Sequel II DNA/RNA sequencing systems, reagent kits, consumables, and preventative maintenance services. This contract is not designated as a set-aside. Pacific Biosciences is a manufacturer of specialized scientific equipment and a major provider of sequencing...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID) to Pacific Biosciences of California, Inc., a for-profit manufacturer of genomic sequencing equipment and consumables. The $363,000.00 firm-fixed-price purchase order is for the provision of a Sequel Instrument, which is part of Pacific Biosciences' proprietary single molecule, real-time (SMRT) sequencing technology. This award was not set aside for any specific business type. Pacific...
- This federal contract award is for the provision of Pacific Biosciences' proprietary reagent kits to support genomic research initiatives at the National Institute of Allergy and Infectious Diseases, which is part of the Department of Health and Human Services. The $11,864.64 firm fixed price purchase order has a completion date of July 3, 2024 and was awarded on April 4, 2024 to Pacific Biosciences of California, Inc., a manufacturer of specialized scientific equipment, reagents, and services...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm-fixed-price purchase order to Pacific Biosciences of California, Inc. for $104,800.00 to provide a SHORT-READ NEXT GENERATION SEQUENCING PLATFORM (ONSO SYSTEM). The contract does not have a set-aside designation and is for the delivery of Pacific Biosciences' Sequel and Sequel II DNA/RNA sequencing platforms, associated consumables, and related services. This award is part of a larger $13.5 million single-award...
- This federal contract award from the National Institute of Allergy and Infectious Diseases to Pacific Biosciences of California, Inc. is for the provision of Pacific Bioscience Kits and Reagents. The $15,095.50 firm fixed-price purchase order does not have a set-aside designation. Pacific Biosciences is the original equipment manufacturer for their proprietary single molecule, real-time (SMRT) sequencing technology, which is utilized by various federal agencies to support genomic research...
- This federal contract award to Pacific Biosciences of California, Inc. is for the provision of the company's Sequel and Sequel II DNA/RNA sequencing systems, associated reagents, kits, and consumables to support genomic research initiatives across several U.S. government agencies, including the Department of Health and Human Services National Institutes of Health, Department of Agriculture, Food and Drug Administration, and Department of Defense. The $384,376.00 firm fixed-price purchase order...